Shout out to MJS719, for the update for Creativ Microtech.

Live link again.
https://www.prnewswire.com/news-releases/life...12481.html

There’s a bit about them at the end that I find interesting, and then an internal company link where you can read more about PD-1 tests, and CTC and CAML test. LifeTracDx® Blood Tests.

“LifeTracDx® blood tests have many applications including predicting response to a new therapy in just 30 days, providing companion diagnostics such as PD-L1 and drug targets using blood instead of tissue, providing information about aggressiveness of the cancer, detection of minimal residual disease, early detection of cancer recurrence, and cancer screening. For a complete listing of our journal publications and posters, please visit our website at https://creatvbio.com/.”

Aggressiveness, residual, early detection of recurring strike me as significant from a blood tests.

Here are the links from them.

July 2024, CAMLs,

https://www.prnewswire.com/news-releases/crea..._cleartime

March 2025, PD-1.

https://www.prnewswire.com/news-releases/pd-l...99042.html